产品NDC |
产品类型 |
商品名 |
通用名 |
剂型 |
给药途径 |
上市日期 |
市场分类 |
申请号 |
标签持有者 |
活性成分 |
规格 |
规格单位 |
49884-658 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20130521 | NDA AUTHORIZED GENERIC | NDA020838 | Par Pharmaceutical Inc. | CANDESARTAN CILEXETIL | 4 | mg/1 |
49884-659 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20130521 | NDA AUTHORIZED GENERIC | NDA020838 | Par Pharmaceutical Inc. | CANDESARTAN CILEXETIL | 8 | mg/1 |
49884-660 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20130521 | NDA AUTHORIZED GENERIC | NDA020838 | Par Pharmaceutical Inc. | CANDESARTAN CILEXETIL | 16 | mg/1 |
49884-661 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20130521 | NDA AUTHORIZED GENERIC | NDA020838 | Par Pharmaceutical Inc. | CANDESARTAN CILEXETIL | 32 | mg/1 |
0186-0004 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan cilexetil | TABLET | ORAL | 19980914(已中止上市,日期20201231) | NDA | NDA020838 | AstraZeneca Pharmaceuticals LP | CANDESARTAN CILEXETIL | 4 | mg/1 |
0186-0008 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan cilexetil | TABLET | ORAL | 19980914(已中止上市,日期20201231) | NDA | NDA020838 | AstraZeneca Pharmaceuticals LP | CANDESARTAN CILEXETIL | 8 | mg/1 |
0186-0016 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan cilexetil | TABLET | ORAL | 19980914(已中止上市,日期20201031) | NDA | NDA020838 | AstraZeneca Pharmaceuticals LP | CANDESARTAN CILEXETIL | 16 | mg/1 |
0186-0032 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan cilexetil | TABLET | ORAL | 19980914(已中止上市,日期20201231) | NDA | NDA020838 | AstraZeneca Pharmaceuticals LP | CANDESARTAN CILEXETIL | 32 | mg/1 |
62559-640 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan Cilexetil | TABLET | ORAL | 20181001 | NDA | NDA020838 | ANI Pharmaceuticals, Inc. | CANDESARTAN CILEXETIL | 4 | mg/1 |
62559-641 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan Cilexetil | TABLET | ORAL | 20181001 | NDA | NDA020838 | ANI Pharmaceuticals, Inc. | CANDESARTAN CILEXETIL | 8 | mg/1 |
62559-642 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan Cilexetil | TABLET | ORAL | 20181001 | NDA | NDA020838 | ANI Pharmaceuticals, Inc. | CANDESARTAN CILEXETIL | 16 | mg/1 |
62559-643 | HUMAN PRESCRIPTION DRUG | ATACAND | Candesartan Cilexetil | TABLET | ORAL | 20181001 | NDA | NDA020838 | ANI Pharmaceuticals, Inc. | CANDESARTAN CILEXETIL | 32 | mg/1 |
60687-119 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20150818 | NDA AUTHORIZED GENERIC | NDA020838 | American Health Packaging | CANDESARTAN CILEXETIL | 8 | mg/1 |
60687-130 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20150924 | NDA AUTHORIZED GENERIC | NDA020838 | American Health Packaging | CANDESARTAN CILEXETIL | 32 | mg/1 |
60687-241 | HUMAN PRESCRIPTION DRUG | Candesartan cilexetil | Candesartan cilexetil | TABLET | ORAL | 20160912 | NDA AUTHORIZED GENERIC | NDA020838 | American Health Packaging | CANDESARTAN CILEXETIL | 16 | mg/1 |